| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |